Skip to content
Annika Bansal – Lifestyle
Author:
Eikon Therapeutics, Inc.
Eikon Therapeutics Announces Seven Abstracts Accepted for Presentation at the 2026 European Society of Medical Oncology (ESMO) Congress
July 20, 2026
Eikon Therapeutics to Join the Russell 3000® Index
June 25, 2026
Eikon Therapeutics Announces the Appointment of Ma. Fatima D. Francisco to its Board of Directors
June 8, 2026
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 30, 2026
←
Previous Page
1
2